# EDGAR Filing Document

**Accession Number:** 0001042893
**File Stem:** 0001315863-26-000230
**Filing Date:** 2026-2
**Character Count:** 75322
**Document Hash:** bd2625b9fd1c209c9c0ce63913892233
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001315863-26-000230.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001315863-26-000230

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Innovex International, Inc.
- **CENTRAL INDEX KEY:** 0001042893
- **STANDARD INDUSTRIAL CLASSIFICATION:** OIL & GAS FILED MACHINERY & EQUIPMENT [3533]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 742162088
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-53041
- **FILM NUMBER:** 26703006

**BUSINESS ADDRESS:**
- **STREET 1:** 19120 KENSWICK DRIVE
- **CITY:** HUMBLE
- **STATE:** TX
- **ZIP:** 77338
- **BUSINESS PHONE:** 3463980000

**MAIL ADDRESS:**
- **STREET 1:** 19120 KENSWICK DRIVE
- **CITY:** HUMBLE
- **STATE:** TX
- **ZIP:** 77338

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DRIL-QUIP INC
- **DATE OF NAME CHANGE:** 19970723
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Amberjack Capital Fund II, L.P.
- **CENTRAL INDEX KEY:** 0001944811

**ORGANIZATION NAME:**
- **EIN:** 883793616
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** AMBERJACK CAPITAL PARTNERS, L.P.
- **STREET 2:** 1021 MAIN ST, SUITE 1100
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77002
- **BUSINESS PHONE:** (281) 605-3900

**MAIL ADDRESS:**
- **STREET 1:** AMBERJACK CAPITAL PARTNERS, L.P.
- **STREET 2:** 1021 MAIN ST, SUITE 1100
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77002

## Exhibit 99.2

#### Exhibit 99.2
LOCK-UP AGREEMENT

February 25, 2026

J.P. MORGAN SECURITIES LLC<br> As Representative of<br> the several Underwriters listed in<br> Schedule 1 to the Underwriting<br> Agreement referred to below

<br>c/o J.P. Morgan Securities LLC<br> 270 Park Avenue<br> New York, NY 10017

Re: **Innovex International, Inc.** --- Public Offering

Ladies and Gentlemen:

The undersigned understands that you, as Representative of the several Underwriters, propose to enter into an underwriting agreement (the "Underwriting Agreement") with Innovex International, Inc., a Delaware corporation (the "Company"), and the Selling Stockholders listed on Schedule 2 to the Underwriting Agreement, providing for the public offering (the "Public Offering") by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the "Underwriters") of shares of common stock, par value $0.01 per share, of the Company (the "Securities"). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.

In consideration of the Underwriters' agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of J.P. Morgan Securities LLC on behalf of the Underwriters, the undersigned will not, and will not cause any affiliate to, during the period beginning on the date of this letter agreement (this "Letter Agreement") and ending at the close of business 45 days after the date of the final prospectus relating to the Public Offering (the "Prospectus") (such period, the "Restricted Period"), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of common stock, par value $0.01 per share, of the Company (the "Common Stock") or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively with the Common Stock, the "Lock-Up Securities"), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for, or exercise any right with respect to, the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of the foregoing. The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (whether by the undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Lock-Up Securities, in cash or otherwise.

Notwithstanding the foregoing, the undersigned may:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) transfer the undersigned's Lock-Up Securities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) as a bona fide gift or gifts or charitable contribution, or for bona fide estate planning purposes,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) by will or intestacy,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to any immediate family member of the undersigned, any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned, or if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement, "immediate family" shall mean any relationship by blood, current or former marriage, domestic partnership or adoption, not more remote than first cousin),

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) to a corporation, partnership, limited liability company or other entity of which the undersigned and the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as part of a distribution to members, limited or general partners or shareholders of the undersigned,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or order of regulatory agency,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such employee,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) to the extent such Lock-Up Securities were acquired in open market transactions after the closing date for the Public Offering,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) to the Company in connection with the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of Common Stock (including, in each case, by way of "net" or "cashless" exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants or rights, provided that any such shares of Common Stock received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement, and provided further that any such restricted stock units, options, warrants or rights are held by the undersigned pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company and made to all holders of the Company's capital stock involving a Change of Control (as defined below) of the Company (for purposes hereof, "Change of Control" shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold at least a majority of the outstanding voting securities of the Company (or the surviving entity)); <u>provided</u> that in the event that such tender offer, merger, consolidation or other similar transaction is not completed, the undersigned's Lock-Up Securities shall remain subject to the provisions of this Letter Agreement;

<u>provided</u> that (A) in the case of any transfer or distribution pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), such transfer shall not involve a disposition for value and each donee, devisee, transferee or distributee shall execute and deliver to the Representative a lock-up letter in the form of this Letter Agreement, (B) in the case of any transfer or distribution pursuant to clause (a)(i), (ii), (iii), (iv), (v), (vi), (ix) and (x), no filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form 3, 4 or 5 or Schedule 13D, 13F or 13G that is required to be filed during the Restricted Period referred to above) and (C) in the case of any transfer or distribution pursuant to clause (a) (viii) it shall be a condition to such transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection with such transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) exercise outstanding options, settle restricted stock units or other equity awards or exercise warrants pursuant to plans described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-Up Securities received upon such exercise, vesting or settlement shall be subject to the terms of this Letter Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) convert outstanding preferred stock, warrants to acquire preferred stock or convertible securities into shares of Common Stock or warrants to acquire shares of Common Stock; provided that any such shares of Common Stock or warrants received upon such conversion shall be subject to the terms of this Letter Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) establish trading plans pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of Lock-Up Securities; <u>provided</u> that (1) such plans do not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) no filing by any party under the Exchange Act or other public announcement shall be required or made voluntarily in connection with such trading plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) transfer or sell Lock-Up Securities pursuant to any trading plan under Rule 10b5-1 under the Exchange Act that has been entered into by the undersigned prior to the date of this Letter Agreement, provided that any filing required to be made under Section 16(a) of the Exchange Act as a result of such transfer or sale shall state that such transfer or sale is pursuant to a trading plan pursuant to Rule 10b5-1; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) sell the Securities to be sold by the undersigned pursuant to the terms of the Underwriting Agreement.

In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.

The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned.

The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Representative may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Representative and the other Underwriters are not making a recommendation to you to participate in the Public Offering, enter into this Letter Agreement, or sell any Shares at the price determined in the Public Offering, and nothing set forth in such disclosures is intended to suggest that the Representative or any Underwriter is making such a recommendation.

The undersigned understands that, if the Underwriting Agreement does not become effective by 9:30 A.M., New York City time, on February 27, 2026, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, or if the Company notifies the Representative that the Company does not intend to proceed with the Public Offering or if the Representative notifies the Company that the Underwriters do not intend to proceed with the Public Offering, the undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement.

Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. §§ 301-309), as amended from time to time, or other applicable law will be deemed original signatures for purposes of this Letter Agreement. Transmission by telecopy, electronic mail or other transmission method of an executed counterpart of this Letter Agreement will constitute due and sufficient delivery of such counterpart.

This Letter Agreement and any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York.

Very truly yours,

[NAME OF STOCKHOLDER]

By: <br> Name:<br> Title:

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 2)**

**Innovex International, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.01 per share**

*(Title of Class of Securities)*

**457651107**

*(CUSIP Number)*

**Jason Turowsky**<br>Amberjack Capital Partners, L.P.<br>4400 Post Oak Parkway, Suite 2760<br>Houston TX 77002<br>(281) 605-3900

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/25/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Amberjack Capital Fund II, L.P.** | Name of reporting person<br>**Amberjack Capital Fund II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**24.6%** | Percent of class represented by amount in Row (11)<br>**24.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovex Co-Invest Fund II, L.P.** | Name of reporting person<br>**Innovex Co-Invest Fund II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3939330.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3939330.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3939330.00** | Aggregate amount beneficially owned by each reporting person<br>**3939330.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.7%** | Percent of class represented by amount in Row (11)<br>**5.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovex Co-Invest Fund, L.P.** | Name of reporting person<br>**Innovex Co-Invest Fund, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**933624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**933624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**933624.00** | Aggregate amount beneficially owned by each reporting person<br>**933624.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.4%** | Percent of class represented by amount in Row (11)<br>**1.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital Fund II, L.P.** | Name of reporting person<br>**Intervale Capital Fund II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**805355.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**805355.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**805355.00** | Aggregate amount beneficially owned by each reporting person<br>**805355.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.2%** | Percent of class represented by amount in Row (11)<br>**1.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital Fund II-A, L.P.** | Name of reporting person<br>**Intervale Capital Fund II-A, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**399.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**399.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**399.00** | Aggregate amount beneficially owned by each reporting person<br>**399.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0%** | Percent of class represented by amount in Row (11)<br>**0%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital Fund III, L.P.** | Name of reporting person<br>**Intervale Capital Fund III, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.3%** | Percent of class represented by amount in Row (11)<br>**0.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Amberjack Capital GP II, L.P.** | Name of reporting person<br>**Amberjack Capital GP II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**24.6%** | Percent of class represented by amount in Row (11)<br>**24.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovex Co-Invest Fund II GP, L.P.** | Name of reporting person<br>**Innovex Co-Invest Fund II GP, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3939330.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3939330.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3939330.00** | Aggregate amount beneficially owned by each reporting person<br>**3939330.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**5.7%** | Percent of class represented by amount in Row (11)<br>**5.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovex Co-Invest Fund GP, L.P.** | Name of reporting person<br>**Innovex Co-Invest Fund GP, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**933624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**933624.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**933624.00** | Aggregate amount beneficially owned by each reporting person<br>**933624.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.4%** | Percent of class represented by amount in Row (11)<br>**1.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital GP II, L.P.** | Name of reporting person<br>**Intervale Capital GP II, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**805754.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**805754.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**805754.00** | Aggregate amount beneficially owned by each reporting person<br>**805754.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.2%** | Percent of class represented by amount in Row (11)<br>**1.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital GP III, L.P.** | Name of reporting person<br>**Intervale Capital GP III, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.3%** | Percent of class represented by amount in Row (11)<br>**0.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Amberjack Capital Associates II, LLC** | Name of reporting person<br>**Amberjack Capital Associates II, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**16871374.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | Aggregate amount beneficially owned by each reporting person<br>**16871374.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**24.6%** | Percent of class represented by amount in Row (11)<br>**24.6%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovex Co-Invest Associates, LLC** | Name of reporting person<br>**Innovex Co-Invest Associates, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**4872954.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**4872954.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4872954.00** | Aggregate amount beneficially owned by each reporting person<br>**4872954.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**7.1%** | Percent of class represented by amount in Row (11)<br>**7.1%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Interval Capital Associates II, LLC** | Name of reporting person<br>**Interval Capital Associates II, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**805754.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**805754.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**805754.00** | Aggregate amount beneficially owned by each reporting person<br>**805754.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**1.2%** | Percent of class represented by amount in Row (11)<br>**1.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Intervale Capital Associates III, LLC** | Name of reporting person<br>**Intervale Capital Associates III, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**207240.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | Aggregate amount beneficially owned by each reporting person<br>**207240.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.3%** | Percent of class represented by amount in Row (11)<br>**0.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Amberjack Capital Partners, L.P.** | Name of reporting person<br>**Amberjack Capital Partners, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.2%** | Percent of class represented by amount in Row (11)<br>**33.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IA** | Type of Reporting Person (See Instructions)<br>**IA** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Amberjack Management, LLC** | Name of reporting person<br>**Amberjack Management, LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.2%** | Percent of class represented by amount in Row (11)<br>**33.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **457651107** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Turowsky Jason** | Name of reporting person<br>**Turowsky Jason** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**22757322.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | Aggregate amount beneficially owned by each reporting person<br>**22757322.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.2%** | Percent of class represented by amount in Row (11)<br>**33.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.01 per share

**(b) Name of Issuer:**
Innovex International, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
19120 Kenswick Drive, Humble, TX, 77338

This Amendment No. 2 to Schedule 13D amends and supplements the Schedule 13D filed by the undersigned with the Securities and Exchange Commission (the "SEC") on September 13, 2024, as amended by Amendment No. 1 dated March 6, 2025 (the "Schedule 13D"). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.

**Item 4. Purpose of Transaction**

Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following:

Underwriting Agreement

On February 25, 2026, the Issuer entered into an Underwriting Agreement (the "Underwriting Agreement") with Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund, L.P., Innovex Co-Invest Fund II, L.P., (collectively, the "Seller Stockholders") and J.P. Morgan Securities LLC, as representative of the several underwriters listed on Schedule 1 thereto (the "Underwriters"), relating to the offer and sale by the Selling Stockholders of 5,750,000 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), at a price to the public of $25.75 per share (the "Offering"). The Selling Stockholders received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts. In addition, the Selling Stockholders granted the Underwriters a 30-day option to purchase up to an additional 862,500 shares of Common Stock ("Option"). On February 27, 2026, the Underwriters exercised the Option in full. 

Amberjack Capital Fund II, L.P. sold 4,902,244 shares of Common Stock to the Underwriters, consisting of (i) 4,262,820 shares of Common Stock in the Offering and (ii) 639,424 shares of Common Stock after the Underwriters' exercise of the Option. Innovex Co-Invest Fund II, L.P. sold 1,144,635 shares of Common Stock to the Underwriters, consisting of (i) 995,335 shares of Common Stock in the Offering and (ii) 149,300 shares of Common Stock after the Underwriters' exercise of the Option. Innovex Co-Invest Fund, L.P. sold 271,279 shares of Common Stock to the Underwriters, consisting of (i) 235,895 shares of Common Stock in the Offering and (ii) 35,384 shares of Common Stock after the Underwriters' exercise of the Option. Intervale Capital Fund II, L.P. sold 234,009 shares of Common Stock to the Underwriters, consisting of (i) 203,486 shares of Common Stock in the Offering and (ii) 30,523 shares of Common Stock after the Underwriters' exercise of the Option. Intervale Capital Fund II-A, L.P. sold 116 shares of Common Stock to the Underwriters, consisting of (i) 101 shares of Common Stock in the Offering and (ii) 15 shares of Common Stock after the Underwriters' exercise of the Option. Intervale Capital Fund III, L.P. sold 60,217 shares of Common Stock to the Underwriters, consisting of (i) 52,363 shares of Common Stock in the Offering and (ii) 7,854 shares of Common Stock after the Underwriters' exercise of the Option.

The Underwriting Agreement also provided for the Issuer's purchase from the Underwriters of 575,000 shares of Common Stock that were subject to the Offering (the "Share Repurchase"). The Share Repurchase was made pursuant to the Issuer's existing share repurchase program. 

The Offering and the Share Repurchase closed on February 27, 2026. The Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination provisions. 

The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is incorporated by reference as Exhibit 99.1 and is incorporated herein by reference.

Lock-up Agreement 

On February 25, 2026, the Issuer entered into a lock-up agreement with the Selling Stockholders (the "Lockup Agreement"). Under the Lockup-Agreement, the Selling Stockholders agreed to not and not to cause any affiliates to, during the period beginning on the date of the Lock-up Agreement and ending at the close of business 45 days after the date of the final prospectus relating the Offering, to transfer any Common Stock or any shares underlying such Common Stock without the prior written consent of the Underwriters, subject to certain exceptions. 

The foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Form of Lock-Up Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is hereby amended and restated as follows:

Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. Such information is based on 68,563,690 shares of Common Stock of the Issuer outstanding as of February 27, 2026, as reported in the Issuer's Prospectus Supplement filed with the SEC on February 27, 2026.

i.	Amberjack Capital Fund II

As of the date hereof, Amberjack Capital Fund II beneficially owns 16,871,374 shares of Common Stock.

Percentage: 24.6%

ii.	Innovex Co-Invest Fund II

As of the date hereof, Innovex Co-Invest Fund II beneficially owns 3,939,330 shares of Common Stock.

Percentage: 5.7%

iii.	Innovex Co-Invest Fund

As of the date hereof, Innovex Co-Invest Fund beneficially owns 933,624 shares of Common Stock.

Percentage: 1.4%

iv.	Intervale Capital Fund II

As of the date hereof, Intervale Capital Fund II beneficially owns 805,355 shares of Common Stock.

Percentage: 1.2%

v.	Intervale Capital Fund II-A

As of the date hereof, Intervale Capital Fund II-A beneficially owns 399 shares of Common Stock.

Percentage: 0.0%

vi.	Intervale Capital Fund III

As of the date hereof, Intervale Capital Fund III beneficially owns 207,240 shares of Common Stock.

Percentage: 0.3%

vii.	Amberjack Capital GP II

Amberjack Capital GP II, as the general partner of Amberjack Capital Fund II, may be deemed the beneficial owner of the 16,871,374 shares of Common Stock owned by Amberjack Capital Fund II.

Percentage: 24.6%

viii.	Innovex Co-Invest Fund II GP

Innovex Co-Invest Fund II GP, as the general partner of Innovex Co-Invest Fund II, may be deemed the beneficial owner of the 3,939,330 shares of Common Stock owned by Innovex Co-Invest Fund II.

Percentage: 5.7%

ix.	Innovex Co-Invest Fund GP

Innovex Co-Invest Fund GP, as the general partner of Innovex Co-Invest Fund, may be deemed the beneficial owner of the 933,624 shares of Common Stock owned by Innovex Co-Invest Fund.

Percentage: 1.4%

x.	Intervale Capital GP II

Intervale Capital GP II, as the general partner of Intervale Capital Fund II and Intervale Capital Fund II-A, may be deemed the beneficial owner of 805,754 shares of Common Stock, comprised of the (i) 805,355 shares of Common Stock owned by Intervale Capital Fund II and (ii) 399 shares of Common Stock owned by Intervale Capital Fund II-A.

Percentage: 1.2%

xi.	Intervale Capital GP III

Intervale Capital GP III, as the general partner of Intervale Capital Fund III, may be deemed the beneficial owner of the 207,240 shares of Common Stock owned by Intervale Capital Fund III.

Percentage: 0.3%

xii.	Amberjack Capital Associates II

Amberjack Capital Associates II, as the general partner of Amberjack Capital GP II, may be deemed the beneficial owner of the 16,871,374 shares of Common Stock owned by Amberjack Capital Fund II.

Percentage: 24.6%

xiii.	Innovex Co-Invest Associates

Innovex Co-Invest Associates, as the general partner of Innovex Co-Invest Fund II GP and Innovex Co-Invest Fund GP, may be deemed the beneficial owner of 4,872,954 shares of Common Stock, comprised of the (i) 3,939,330 shares of Common Stock owned by Innovex Co-Invest Fund II and (ii) 933,624 shares of Common Stock owned by Innovex Co-Invest Fund.

Percentage: 7.1%

xiv.	Intervale Capital Associates II

Intervale Capital Associates II, as the general partner of Intervale Capital GP II, may be deemed the beneficial owner of 805,754 shares of Common Stock, comprised of the (i) 805,355 shares of Common Stock owned by Intervale Capital Fund II and (ii) 399 shares of Common Stock owned by Intervale Capital Fund II-A.

Percentage: 1.2%

xv.	Intervale Capital Associates III

Intervale Capital Associates III, as the general partner of Intervale Capital GP III, may be deemed the beneficial owner of the 207,240 shares of Common Stock owned by Intervale Capital Fund III.

Percentage: 0.3%

xvi.	Amberjack Capital Partners

Amberjack Capital Partners, as the sole member of Amberjack Capital Associates II, Innovex Co-Invest Associates, Intervale Capital Associates II, and Intervale Capital Associates III, may be deemed the beneficial owner of 22,757,322 shares of Common Stock, comprised of the (i) 16,871,374 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,939,330 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 933,624 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 805,355 shares of Common Stock owned by Intervale Capital Fund II, (v) 399 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 207,240 shares of Common Stock owned by Intervale Capital Fund III.

Percentage: 33.2%

xvii.	Amberjack Management

Amberjack Management, as the general partner of Amberjack Capital Partners, may be deemed the beneficial owner of 22,757,322 shares of Common Stock, comprised of the (i) 16,871,374 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,939,330 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 933,624 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 805,355 shares of Common Stock owned by Intervale Capital Fund II, (v) 399 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 207,240 shares of Common Stock owned by Intervale Capital Fund III.

Percentage: 33.2%

xviii.	Jason Turowsky

Jason Turowsky, as managing partner of Amberjack Management, may be deemed the beneficial owner of 22,757,322 shares of Common Stock, comprised of the (i) 16,871,374 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,939,330 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 933,624 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 805,355 shares of Common Stock owned by Intervale Capital Fund II, (v) 399 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 207,240 shares of Common Stock owned by Intervale Capital Fund III.

Percentage: 33.2%

**(b)**
i.	Amberjack Capital Fund II

1. Sole power to vote or direct vote: 16,871,374
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 16,871,374
4. Shared power to dispose or direct the disposition: 0

ii.	Innovex Co-Invest Fund II

1. Sole power to vote or direct vote: 3,939,330
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 3,939,330
4. Shared power to dispose or direct the disposition: 0

iii.	Innovex Co-Invest Fund

1. Sole power to vote or direct vote: 933,624
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 933,624
4. Shared power to dispose or direct the disposition: 0

iv.	Intervale Capital Fund II

1. Sole power to vote or direct vote: 805,355
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 805,355
4. Shared power to dispose or direct the disposition: 0

v.	Intervale Capital Fund II-A

1. Sole power to vote or direct vote: 399
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 399
4. Shared power to dispose or direct the disposition: 0

vi.	Intervale Capital Fund III

1. Sole power to vote or direct vote: 207,240
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 207,240
4. Shared power to dispose or direct the disposition: 0

vii.	Amberjack Capital GP II

1. Sole power to vote or direct vote: 16,871,374
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 16,871,374
4. Shared power to dispose or direct the disposition: 0

viii.	Innovex Co-Invest Fund II GP

1. Sole power to vote or direct vote: 3,939,330
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 3,939,330
4. Shared power to dispose or direct the disposition: 0

ix.	Innovex Co-Invest Fund GP

1. Sole power to vote or direct vote: 933,624
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 933,624
4. Shared power to dispose or direct the disposition: 0

x.	Intervale Capital GP II

1. Sole power to vote or direct vote: 805,754
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 805,754
4. Shared power to dispose or direct the disposition: 0

xi.	Intervale Capital GP III

1. Sole power to vote or direct vote: 207,240
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 207,240
4. Shared power to dispose or direct the disposition: 0

xii.	Amberjack Capital Associates II

1. Sole power to vote or direct vote: 16,871,374
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 16,871,374
4. Shared power to dispose or direct the disposition: 0

xiii.	Innovex Co-Invest Associates

1. Sole power to vote or direct vote: 4,872,954
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 4,872,954
4. Shared power to dispose or direct the disposition: 0

xiv.	Intervale Capital Associates II

1. Sole power to vote or direct vote: 805,754
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 805,754
4. Shared power to dispose or direct the disposition: 0

xv.	Intervale Capital Associates III

1. Sole power to vote or direct vote: 207,240
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 207,240
4. Shared power to dispose or direct the disposition: 0

xvi.	Amberjack Capital Partners

1. Sole power to vote or direct vote: 22,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 22,757,322
4. Shared power to dispose or direct the disposition: 0

xvii.	Amberjack Management

1. Sole power to vote or direct vote: 22,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 22,757,322
4. Shared power to dispose or direct the disposition: 0

xviii.	Jason Turowsky

1. Sole power to vote or direct vote: 22,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 22,757,322
4. Shared power to dispose or direct the disposition: 0

**(c)**
The information in Item 4 is incorporated herein by reference. Except as disclosed in this Schedule 13D, there have been no transactions in the shares of Common Stock effected by the Reporting Persons on behalf of the Funds in the past 60 days.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Amberjack Capital Fund II, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Amberjack Capital Associates II, LLC, the general partner of Amberjack Capital GP II, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovex Co-Invest Fund II, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, the general partner of Innovex Co-Invest Fund II GP, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovex Co-Invest Fund, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, the general partner of Innovex Co-Invest Fund GP, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital Fund II, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates II, LLC, the general partner of Intervale Capital GP II, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital Fund II-A, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates II, LLC, the general partner of Intervale Capital GP II, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital Fund III, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates III, LLC, the general partner of Intervale Capital GP III, L.P., its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Amberjack Capital GP II, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates II, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovex Co-Invest Fund II GP, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovex Co-Invest Fund GP, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Innovex Co-Invest Associates, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital GP II, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates II, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital GP III, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Intervale Capital Associates III, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Amberjack Capital Associates II, LLC

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovex Co-Invest Associates, LLC

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Interval Capital Associates II, LLC

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Intervale Capital Associates III, LLC

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Amberjack Capital Partners, L.P.

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner of Amberjack Management, LLC, its general partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Amberjack Management, LLC

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky / Partner

**Date:** 02/27/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Turowsky Jason

**Signature:** /s/ Jason Turowsky

**Name/Title:** Jason Turowsky /Self

**Date:** 02/27/2026